Stephen Falk

Stephen Falk

UNVERIFIED PROFILE

Are you Stephen Falk?   Register this Author

Register author
Stephen Falk

Stephen Falk

Publications by authors named "Stephen Falk"

Are you Stephen Falk?   Register this Author

49Publications

1618Reads

7Profile Views

A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS.

Br J Cancer 2018 09 17;119(6):697-706. Epub 2018 Aug 17.

Centre for Trials Research, Cardiff University, Room 409, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4YS, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0209-4DOI Listing
September 2018

Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer.

J Clin Oncol 2017 Jul 24;35(20):2279-2287. Epub 2017 May 24.

Russell D. Petty, University of Dundee; Asa Dahle-Smith, Ninewells Hospital and Medical School, Dundee; David A.J. Stevenson, Aileen Osborne, Doreen Massie, Caroline Clark, Zosia Miedzybrodzka, and Graeme I. Murray, University of Aberdeen, Aberdeen; Susan J. Dutton and Corran Roberts, Centre for Statistics in Medicine, University of Oxford, Oxford; Mark Harrison, Mount Vernon Hospital, Northwood; Irene Y. Chong and Ian Chau, Royal Marsden Hospital, London and Surrey; Wasat Mansoor, Christie Hospital, Manchester; Joyce Thompson, Birmingham Heartland Hospital, Heart of England National Health Service Trust, Birmingham; Anirban Chatterjee, Royal Shrewsbury Hospital, Shrewsbury; Stephen J. Falk, Bristol Oncology Centre, Bristol; Sean Elyan, Cheltenham General Hospital, Cheltenham; Angel Garcia-Alonso, Clan Clwyd Hospital, Rhyl; David Walter Fyfe, Furness General Hospital, Furness; Jonathan Wadsley, Weston Park Hospital, Sheffield, United Kingdom; and David R. Ferry, Eli Lilly and Company, Bridgewater, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3934DOI Listing
July 2017

Risk of premature menopause after treatment for Hodgkin's lymphoma.

J Natl Cancer Inst 2014 Sep 19;106(9). Epub 2014 Aug 19.

Divisions of Genetics and Epidemiology (AJS, RC), Breast Cancer Research (AJS) and Radiotherapy (AH), Institute of Cancer Research, Sutton, UK; University of Manchester and Christie NHS Foundation Trust, Manchester, UK (JR); Gastrointestinal Unit, Royal Marsden Hospital, Sutton, UK (DC); Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, UK (IS); Cancer Research UK Medical Oncology Unit, St. Bartholomew's Hospital, London, UK (TAL); Cancer Centre, Mount Vernon Hospital, Middlesex, UK (PJH); St. James Institute of Oncology, Leeds, UK (DG); Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK (HHL); Bristol Haematology and Oncology Centre, Bristol, UK (SJF); Addenbrooke's Hospital, Cambridge, UK (MVW); Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield, UK (BWH); Guy's and St. Thomas, London, UK (SJH); Department of Haematology, University College Hospital, London, UK (DCL); Southampton General Hospital, Southampton, UK (AB); Queen Elizabeth Hospital, Birmingham, UK (AMS). The England and Wales Hodgkin Lymphoma Follow-up Group includes the authors of this article plus: Gabriel Anghel, Lincoln Hospital; Brian Attock, North Devon District Hospital; Jane Barrett, Royal Berkshire Hospital; Andrew Bell, Poole Hospital; Kim Benstead, Cheltenham General Hospital; Eric M. Bessell, Nottingham University Hospital; Ashoke Biswas, Royal Preston Hospital; Norbert Blesing, Great Western Hospital, Swindon; Caroline Brammer, New Cross Hospital, Wolverhampton; Jill Brock, Clatterbridge Centre for Oncology; Alison Brownell, Queens Hospital, Romford; A. Murray Brunt, University Hospital of North Staffordshire; Peter B. Coates, Queen Elizabeth Hospital, King's Lynn; Matthew P. Collinson, Royal Cornwall Hospital; Neville Davidson, Essex County Hospital; Sian Davies, North Middlesex University Hospital; Ian Fentiman, Guy's Hospital; Eve Gallop-Evans, Velindre Hospital; Angel Garcia, Glan Clwyd Hospital; Andrew Goodman, Royal Devon and Exeter Hospital; Ad

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju207DOI Listing
September 2014

Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature.

Dis Colon Rectum 2013 Jul;56(7):921-30

Department of Research and Development, Yeovil District Hospital, Yeovil, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/DCR.0b013e31828aedcbDOI Listing
July 2013

Lymphomas of the upper GI tract: the role of radiotherapy.

Authors:
Stephen Falk

Clin Oncol (R Coll Radiol) 2012 Jun 2;24(5):352-7. Epub 2012 Mar 2.

Bristol Haematology and Oncology Centre, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clon.2012.02.003DOI Listing
June 2012

Positron emission tomography scanning in oesophageal cancer - stuck at the first hurdle?

Authors:
Stephen Falk

Clin Oncol (R Coll Radiol) 2012 Mar 23;24(2):83-5. Epub 2011 Aug 23.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clon.2011.08.001DOI Listing
March 2012

Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial.

Radiother Oncol 2011 Jul 12;100(1):86-92. Epub 2011 Jun 12.

Haematology Trials Group, University College London Cancer Trials Centre, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2011.05.013DOI Listing
July 2011

Return of the postcode lottery.

BMJ 2010 Dec 30;341:c7389. Epub 2010 Dec 30.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.c7389DOI Listing
December 2010

A multi-centre dose-escalation and pharmacokinetic study of diflomotecan in patients with advanced malignancy.

Cancer Chemother Pharmacol 2009 Apr 25;63(5):945-52. Epub 2008 Jul 25.

The Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, G12 OYN, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-008-0795-6DOI Listing
April 2009

Routine use of continuous, hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer: a five-center experience.

Int J Radiat Oncol Biol Phys 2008 Nov 20;72(3):716-22. Epub 2008 Mar 20.

Department of Clinical Oncology, Weston Park Hospital, Sheffield, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.01.033DOI Listing
November 2008

Health-related quality of life among patients cured by surgery for esophageal cancer.

Cancer 2007 Aug;110(3):686-93

Department of Social Medicine, University of Bristol, Bristol, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22833DOI Listing
August 2007

Decisions to use complementary and alternative medicine (CAM) by male cancer patients: information-seeking roles and types of evidence used.

BMC Complement Altern Med 2007 Aug 4;7:25. Epub 2007 Aug 4.

Academic Unit of Primary Care, Department of Community-based Medicine, University of Bristol, 25-27 Belgrave Road, Bristol BS8 2AA, UK.

View Article

Download full-text PDF

Source
http://bmccomplementalternmed.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/1472-6882-7-25DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2000907PMC
August 2007

Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma.

Cancer 2005 May;103(9):1791-9

Department of Social Medicine, University of Bristol, Bristol, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20980DOI Listing
May 2005

The patients' written word: a simple communication aid.

Patient Educ Couns 2004 Aug;54(2):197-200

Bristol Haematology and Oncology Centre, Horfield Road, Bristol BS2 8ED, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0738-3991(03)00213-1DOI Listing
August 2004